The annual spring meeting is a critical part of updating the yearly flu shot to match the strains most likely to be circulating in the U.S. come wintertime.
The FDA’s abrupt decision to cancel next month’s vaccine advisory committee meeting is raising concerns about whether the U.S ...
A planned meeting of a U.S. Food and Drug Administration committee to recommend the makeup of seasonal flu shots for the 20 ...
Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...
Loss of pulse detection uses the watch's existing heart rate sensor and an AI algorithm that processes the data. It should ...
A bill that would seek to regulate vapor products in the state is now on its way to the Senate floor. The bill passed through ...
What’s it like reporting on the FDA during the early and turbulent weeks of the Trump administration? Why did Bluebird Bio ...
The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...
CMPS earnings call for the period ending December 31, 2024. Compass Pathways Plc ( CMPS 7.30%) Q4 2024 Earnings Call Feb 27, ...
The FDA canceled a critical annual flu vaccine planning meeting without explanation days after Robert F. Kennedy Jr. took ...
NAMI released the following statement from Chief Executive Officer Daniel H. Gillison, Jr., following the Food and Drug ...
As for the second bullish argument, despite today's jump, Catalyst shares are still 46% below analysts' average price target of $32.50. And, although coverage of this company is modest, all eight of ...